Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company
(NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced new
analyses from the DURATION-3 and -4 trials demonstrating patients ... read more
Alkermes,
Inc. (NASDAQ: ALKS) today announced that Alkermes shareholders have
approved the merger of Alkermes and Elan
Drug Technologies (“EDT”), the profitable ... read more
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live from the Morgan Stanley Global
Healthcare Conference on Wednesday, September 14, 2011, at 10:20 ... read more